Literature DB >> 7479193

Revised FDA labeling guideline for theophylline oral dosage forms.

L Hendeles1, J Jenkins, R Temple.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7479193

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN： 0277-0008            Impact factor:   4.705


× No keyword cloud information.
  4 in total

1.  Effect of combination therapy with ciprofloxacin and clarithromycin on theophylline pharmacokinetics in healthy volunteers.

Authors:  J G Gillum; D S Israel; R B Scott; M W Climo; R E Polk
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

2.  Efficacy of L-carnitine and propranolol in the management of acute theophylline toxicity.

Authors:  Naima A Sherif; Asmaa S El-Banna; Marwan M ElBourini; Nancy O Khalil
Journal:  Toxicol Res (Camb)       Date:  2020-03-11       Impact factor: 3.524

Review 3.  Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?

Authors:  T D Holimon; C C Chafin; T H Self
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness.

Authors:  Stephen Brett
Journal:  Crit Care       Date:  2004-10-08       Impact factor: 9.097
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.